| 16:30-17:00 |
Anti-infectious Natural Products from Marine-derived Microbes
Xueting Liu, Associate Professor , CAS Key Laboratory of Pathogenic Microbiology & Immunology |
| 17:00-17:30 |
Topic tbc
Hakim Djaballah - tbc |
| 17:30-19:00 |
Reception |
| 4月10日 星期五 Biologics Innovation Group 2015 Annual Conference |
| 08:45-09:00 |
Welcome Speech- Biologics Enabling Working Group Annual Conference
Bill Jiang,
Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:00-09:45 |
Keynote 2 : Vaccine and Therapeutic Antibody for New Outbreak of Pathogen
Fu Gao, Vice President, Beijing Institutes of Life Science, Chinese Academy of Sciences;
Director, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology; Professor, University of Science and Technology of China |
| 09:45-12:30 |
Session 3: The Scientific Frontier of Biological Discovery |
| Part I |
Co-chairs:
Ying Yang, Founder & CEO, LBD Life Sciences Ltd; Asia Council Chair, Society for Laboratory Automation and Screening (SLAS)
Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:45-10:15 |
Virus and Anti-Virus Drug Discovery
Zihe Rao, Biophysicist & Structural Biologist; Professor & Former President, Nankai University; Academician, Chinese Academy of Sciences; President, Biophysical Society of China; President, International Union of Pure and Applied Biophysics (IUPAB) |
| 10:15-10:45 |
Break in Exhibit Hall |
| Part II |
Co-Chairs:
Guang Yang, Vice Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University
Mingqiang Zhang, Vice President, R&D for China Amgen |
| 10:45-11:15 |
Systems Approach to Translational Medicine
Genhong Cheng, Director, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; Professor, Department of Microbiology, Immunology & Molecular Genetics, UCLA |
| 11:15-11:45 |
Therapeutic Antibody Discovery and Lead Selection
Yan Wu, Associate Director, Genentech |
| 11:45-12:30 |
Feature Talk and Panel Discussion: Case Study-NIBS’s Technology Transfer and Commercialization of Scientific Findings
Moderator: Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd.
Speaker: Xiaodong Wang, Biochemist; Director & Investigator, National Institute of Biological Science, China; Member, National Academy of Sciences, USA
Panelist:
Mingqiang Zhang, Vice President of R&D for China Amgen
Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner
Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 12:30-14:00 |
Lunch in Exhibit Hall |
| 12:30-14:00 |
Posters |
| 13:15-14:00 |
Exhibitor Tutorial 3:
Location: Nanjing Room, Level 5
Sponsored by Exhibitor Tutorial 4:
Location:Suzhou Room, Level 5 |
| 14:00-17:30 |
Session 4: ADC - From Technology, Process, Discovery to Development (To be confirmed) |
| Part I |
Co-chairs:
Xueming Qian, Chairman & CEO, Mabspace Biosciences CO., LTD
Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner |
| 14:00-14:30 |
Antibody-Drug Conjugates for Cancer Therapy: Strategies and Perspectives
Weikang Tao, CSO, Hengrui Pharmaceutical R&D |
| 14:30-15:00 |
Site Specific Conjugation: Improvement of ADC Homogeneity and Druggability Properties
Bruce Nianhe Han, CSO, NewBio Therapeutics |
| 15:00-15:30 |
R&D of Next-generation ADCs Based on LDC Technology
Gang Qin, CEO, GeneQuantum Healthcare (Suzhou) Co., Ltd. |
| 15:30-16:00 |
Biological Characterization of Antibody Drug Conjugates
Mary Hu, CEO, Shanghai Miracogen Inc |
| 16:00-16:30 |
Break in Exhibit Hall |
| Part II |
Co-chairs:
Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation (New York); President, Kadmon China
Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd. |
| 16:30-17:00 |
A New Generation of Antibody-drug Conjugates for the Targeted Treatment of Cancer
Robert Yongxin Zhao, CEO & Chairman, Hangzhou DAC Biotech Co., Ltd. |
| 17:00-17:30 |
Developing a Novel ADC for Global Market via Innovative Three-party Collaboration
Chris Chen, Head of Biologics, Wuxi Apptec |
| 17:30-17:45 |
Closing Remark (awarding) |
【会议嘉宾】
|
Karl Barry Sharpless, Ph.D
Going Fishing for Better Medicines
Nobel Prize Laureate, W. M. Keck Professor of Chemistry, The Scripps Research Institute, California
|
Fu Gao, PhD, MCAS
Vaccine and Therapeutic Antibody for New Outbreak of Pathogen
Deputy Director, Chinese Center for Disease Control and Prevention
|
|
Zihe Rao, PhD, MCAS
Virus and Anti-Virus Drug Discovery
Professor and Former President of Nankai University
|
Xiaodong Wang, PhD, MNAS
Case Study-NIBS’s Technology Transfer and Commercialization of Scientific Findings
Director and Investigator of the National Institute of Biological Science, China
|
【会议门票】
【会议通知】
实验室自动化与筛选协会2015亚洲年会将于2015年4月9日-10日在上海浦东康桥加入酒店召开。作为推动科学与技术相结合的平台,SLAS聚集了来自全球的18000名生命科学领域的研发精英,包括科学家、技术提供商、研究人员、学术人员和学生、工程师、信息学专家以及商业领袖。SLAS组织并提供全年的教育和交流活动,致力于为全球科学和技术领域的专业人员建立联系并达成合作创新。